
3.22 Delayed Data As of Dec 01 | ![]() Today’s Change | 1.62 Today|||52-Week Range 4.14 | +73.12% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $227.6M |
Ovid Therapeutics, Inc. 441 9th Avenue New York New York 10001 |
Jeremy Max Levin | Chairman, President & Chief Executive Officer |
Jason Tardio | Chief Operating Officer |
Jeffrey A. Rona | Chief Financial & Business Officer |
Julia Tsai | Senior VP-Clinical Development & Medical Affairs |
Manoj Malhotra | Chief Medical Officer |